European Shares Rally as Democrats Take US Congress, Investors Rotate Into Domestic Banks

The Quick Take

• European equities rose as Democratic midterm victories shift expectations toward stable US trade policy
• Novo Nordisk shares surged, adding to European market gains on the session
• Investors rotated into domestically-focused European banks that had lagged the broader market for much of 2026

European equity markets responded positively to the US midterm results, as investors processed the implications of Democratic congressional gains for global trade and economic policy. The rally had two distinct drivers: a broad market re-rating on reduced trade-war tail risk as Republicans lose their legislative majority, and stock-specific outperformance from Novo Nordisk, the Danish pharmaceutical giant whose obesity-drug franchise has become the most significant single-company driver of European equity index performance. Together, these forces lifted European equities despite the late-cycle monetary policy tightening being signalled by ECB policymakers.

The rotation into domestically-focused European banks is particularly significant — this cohort had underperformed for much of 2026 as rising deposit costs squeezed net interest margins and trade uncertainty dampened business investment appetite. With the ECB rate hike path becoming more visible and trade uncertainty partially resolving, banks with predominantly domestic Eurozone revenue can reprice their lending books while facing reduced provisioning headwinds. For Asian investors with European equity exposure, the bank rotation signal is an early tell that the market's sector leadership is shifting from growth and export-driven names back toward financials with earnings certainty.

The forward signals split between the Novo Nordisk-specific narrative and the macro trade story. For Novo Nordisk, watch Q3 results and pipeline data for the semaglutide and next-generation GLP-1 franchise — any clinical setback or competitive threat from Eli Lilly's alternative programs would immediately test the European pharma rally. For the broader European bank rotation trade, the December ECB meeting outcome and 2027 rate path guidance will determine whether domestic banks can reprice margins sustainably. The macro variable is whether Democratic Congressional majority translates into concrete US-EU trade normalization or remains symbolic positioning.

Synthesized from 1 source.